ESG

Aptera Motors built its first validation vehicle, a key step toward delivering its ultra-efficient solar EV to nearly 50,000 reservation holders.

With a new focus and fresh capital, Trigon Metals begins a key drilling campaign at its Addana project, betting on Moroccan silver to power the future.

With promising clinical data for its heart disease treatments, Lexeo Therapeutics aims to capture investor attention at the upcoming Leerink conference.

A new multi-year deal with XCharge will bring 400kW ultra-fast chargers to EnBW's network, aiming for enhanced reliability and European-made hardware.

Amid a booming gene therapy market, Oxford Biomedica Solutions launches key investor events to showcase its strategy and secure its leadership position.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

Three investment heavyweights—BCI, Norges Bank, and Brookfield—have formed Northview Energy, a new firm set to scale de-risked renewable assets.

New research reveals a media blind spot for hearing loss, fueling stigma. A new campaign aims to change the picture and normalize hearing aids for millions.

A new trial for a cell therapy targeting a rare eye disease offers hope, driven by a patient-advocate's journey and with potential to treat common AMD.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

A new partnership aims to solve the AI industry's energy crisis, bringing high-efficiency liquid cooling to thousands of data centers.

Consumer electronics leader AUKEY snags three prestigious iF DESIGN AWARDs, proving that superior design is no longer a luxury—it's the standard.

A new global survey reveals a startling gap between knowing sleep is vital and getting quality rest. Technology tracks our every toss and turn, but is it helping?

Transcelestial unveils CENTAURI+, a laser net with AI healing, 40Gbps speeds, and quantum-safe security to solve the world's bandwidth crisis.

Post-listing, the Swiss HealthTech firm pushes for US market expansion and European reimbursement, streamlining its focus on AI-powered brain health.

A novel CRISPR-based therapy safely targets deadly E. coli in the gut, showing promise in the fight against antibiotic resistance and for protecting cancer patients.

Bisedge's exclusive dealership for Linde Material Handling brings advanced, green tech to East Africa, promising to boost efficiency and empower local firms.

MAIA Biotechnology secured a crucial $30M to advance its promising lung cancer drug, but the move sent its stock plunging amid investor fears of dilution.

With a pivotal trial for pancreatic cancer looming, Immuneering will detail its novel 'Deep Cyclic Inhibitor' platform and strategy to investors.

Little Rapids Corporation merges its paper and packaging arms into Rapids Paper + Packaging, a new entity aimed at tackling plastic waste with integrated solutions.